<code id='2EB31B5968'></code><style id='2EB31B5968'></style>
    • <acronym id='2EB31B5968'></acronym>
      <center id='2EB31B5968'><center id='2EB31B5968'><tfoot id='2EB31B5968'></tfoot></center><abbr id='2EB31B5968'><dir id='2EB31B5968'><tfoot id='2EB31B5968'></tfoot><noframes id='2EB31B5968'>

    • <optgroup id='2EB31B5968'><strike id='2EB31B5968'><sup id='2EB31B5968'></sup></strike><code id='2EB31B5968'></code></optgroup>
        1. <b id='2EB31B5968'><label id='2EB31B5968'><select id='2EB31B5968'><dt id='2EB31B5968'><span id='2EB31B5968'></span></dt></select></label></b><u id='2EB31B5968'></u>
          <i id='2EB31B5968'><strike id='2EB31B5968'><tt id='2EB31B5968'><pre id='2EB31B5968'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:78
          Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT
          Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

          WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

          At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

          advertisement

          Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Humans aren't the only ones with an imagination. Rats have it too
          Humans aren't the only ones with an imagination. Rats have it too

          RYANM.KELLY/AFPviaGettyImagesOurmindshaveaweirdandwondrouswayoftransportingustootherplacesandtimes.Y

          read more
          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more

          After Sarepta trial failure, Duchenne families brace for more debate

          KristofferTripplaar/SipaviaAPTohearSareptaCEODougIngramtellit,theresultsMondayafternoonfromalargetri